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Abstract: Research findings are inconsistent about improvement of specific cardio-metabolic
variables after lifestyle intervention in obese children. The aim of this trial was to evaluate
the effect of a 1-year intervention, based on normocaloric diet and physical activity, on body
mass index (BMI), blood lipid profile, glucose metabolism and metabolic syndrome. Eighty-five
obese children aged ě6 years were analyzed. The BMI z-score was calculated. Fasting blood
samples were analyzed for lipids, insulin and glucose. The homeostatic model assessment of
insulin resistance (HOMA-IR) was calculated and insulin resistance was defined as HOMA-IR
>3.16. HOMA-β%, quantitative insulin sensitivity check index and triglyceride glucose index were
calculated. The metabolic syndrome was defined in accordance with the International Diabetes
Federation criteria. At the end of intervention children showed a reduction (mean (95% CI)) in
BMI z-score (´0.58 (´0.66; ´0.50)), triglycerides (´0.35 (´0.45; ´0.25) mmol/L) and triglyceride
glucose index (´0.29 (´0.37; ´0.21)), and an increase in HDL cholesterol (0.06 (0.01; 0.11) mmol/L).
Prevalence of insulin resistance declined from 51.8% to 36.5% and prevalence of metabolic syndrome
from 17.1% to 4.9%. Nutritional-behavioral interventions can improve the blood lipid profile and
insulin sensitivity in obese children, and possibly provide benefits in terms of metabolic syndrome.
Keywords: childhood obesity; nutritional-behavioral intervention; lipid profile; glucose
metabolism; metabolic syndrome
1. Introduction
Childhood obesity has become a worldwide concern, affecting children of high-income countries
as well as middle-income and low-income countries [1]. Although recent studies suggested
that progresses have been made in the control of the obesity epidemic [2,3] the prevalence of
childhood obesity remains high [1]. Obese children are exposed to detrimental short and long-term
effects on health, thus showing components of metabolic syndrome [4], such as dyslipidemia [5],
hypertension [6], insulin resistance and disturbed glucose metabolism [7]. In most cases, obesity
is consequence of a chronic imbalance between energy intake and energy expenditure, involving
environmental and lifestyle factors, e.g., easy access to energy-dense foods, increased portion sizes,
reduced physical activity and increased time spent in sedentary activities [8]. Chronic exposure over
time to these factors may potentiate weight gain over many years [8].
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Guidelines for treatment of childhood obesity recommend intensive lifestyle interventions,
involving diet, behavioral and physical activity for the child and the entire family, in an
age-appropriate manner [9]. A Cochrane systematic review stated that in children, family-based
lifestyle interventions aimed at changing dietary, behavioral and physical activity patterns can
lead to a reduction in overweight, compared to standard care or self-help [10]. A meta-analysis
of randomized trials conducted on overweight/obese children showed a small to moderate effect
from combined lifestyle interventions on body mass index (BMI) [11]. The largest effects were
observed when lifestyle modifications were implemented with parental involvement [11]. In a recent
meta-analysis, Ho et al. [12] evaluated randomized controlled trials with a follow-up period of at least
2 months from baseline and highlighted that lifestyle interventions, incorporating diet and physical
exercise and/or behavioral treatment, can lead to improvement in weight and cardio-metabolic
outcomes, compared to no treatment/wait-list control, usual care, or written education materials.
These authors also reported that although both diet-only and combined interventions (diet plus
exercise) may result in weight loss and metabolic improvement in the overweight/obese pediatric
population, combined interventions can determine larger improvement in levels of high-density
lipoprotein (HDL) cholesterol, fasting glucose and insulin over 6 months [13]. Other authors
suggested that improved weight status may be achieved by a reduced-energy diet, but the need for
an adequate content of macronutrients has to be considered when aiming at specific cardio-metabolic
risk factors [14]. Studies evaluated the effect of a lifestyle intervention, in overweight/obese children,
characterized by nutritional counseling and education, within an intervention period ranging from
20 weeks to 12 months [15–19]. While a decrease in BMI z-score has been observed [15–19], research
findings are inconsistent about improvement of specific cardio-metabolic variables.
The primary aim of this study was to evaluate whether a 1-year intervention based on
normocaloric diet and physical activity may impact the BMI status, blood lipid profile and glucose
metabolism indicators in obese children. Additionally, metabolic syndrome was assessed.
2. Experimental Section
A cohort of 90 obese children (44 boys and 46 girls) was consecutively recruited among
those admitted with diagnosis of obesity by primary care pediatricians to the Department of
Pediatrics, San Paolo Hospital, Milan, Italy, between 1 January 2012 and 31 December 2014,
according to the following eligibility criteria: age ě6 years, weight at birth ě2500 g and <4000 g,
gestational age 37–42 weeks, single birth, children having white parents and residing in Milan
or neighborhood (<30 km). Children having syndromic, organic and hormonal conditions besides
obesity were excluded.
A child was defined obese in accordance with the International Obesity Task Force, i.e., if her/his
BMI was above the age- and sex-adjusted BMI Cole’s curve passing through the cut-off of 30 kg/m2 at
age 18 years [20]. The parents of eligible children or their legal guardian received detailed explanation
about the aim of the study, and signed a consent form. The Hospital Ethics Committee approved the
study protocol and gave ethical clearance.
2.1. Anthropometry and Blood Pressure
A medical history was collected at recruitment from parents by a standardized questionnaire
during a personal interview conducted by the same pediatrician that saw children for a general
examination and evaluated the Tanner stage of puberty [21]. The pediatrician also took
anthropometric measurements and blood pressure of children both at recruitment and at the end
of intervention, assisted by an experienced operator. Body weight and height were measured
using a mechanical column scale (seca 711; seca GmbH & KG, Hamburg, Germany) with integrated
measuring rod (seca 220; seca GmbH & KG). BMI was calculated from the ratio of weight to height
squared (kg/m2). BMI z-scores were calculated and adjusted for age and sex by using Cole’s LMS
method [22] and Italian reference data [23]. Waist circumference (WC) was measured using the
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measuring tape seca 203 (seca GmbH & KG) to the nearest 0.1 cm at the mid-point between the iliac
crest and the lower edge of the ribs at the end of a normal expiration. Triceps skinfold thickness was
measured on the left side of the body, using the Harpenden Skinfold Caliper (Chasmors Ltd, London,
UK) halfway between the acromion process and the olecranon process [24]. Blood pressure was
measured according to recommendations of the National High Blood Pressure Education Program
Working Group [25].
2.2. Biochemistry
Biochemical measurements were performed within 3 ˘ 1 day (baseline) of recruitment and one
year (˘5 day) after starting intervention (end of intervention). Fasting blood samples were taken
at 8 h ˘ 30 min a.m. and immediately analyzed at the hospital laboratory of biochemistry for total
cholesterol, HDL cholesterol, low-density-lipoprotein (LDL) cholesterol, triglycerides, apolipoprotein
A1, apolipoprotein B, insulin and glucose on the cobasr 6000 analyzer series, c501 and e601
modules (Roche Diagnostics GmbH, Hoffmann-La Roche ltd, Mannheim, Germany), which has
been recognized as providing robust chemistry and immunochemistry [26]. The homeostatic
model assessment of insulin resistance (HOMA-IR) was calculated as the product of fasting
glucose (mmol/L) and fasting insulin (µU/mL) divided by 22.5 [27], and insulin resistance was
defined as HOMA-IR >3.16 [28]. The quantitative insulin sensitivity check (QUICK) index was
calculated as 1/(log10 fasting plasma insulin in µU/mL + log10 glucose in mg/dL) [29]. Pancreatic
β-cell function was evaluated by HOMA-β% as (20 ˆ fasting insulin in µU/mL)/(fasting glucose
in mmol/L ´ 3.5) [27]. The triglyceride glucose index (TyG index) was calculated as ln [fasting
triglycerides (mg/dL) ˆ fasting glucose (mg/dL)/2] [30,31].
2.3. Dietary Habits
Dietary habits of children were assessed at baseline and at the end of intervention by a food
frequency questionnaire (FFQ) originally developed at our Department in 1990’s on the original
Block FFQ [32] and then revised and updated in 2008 on the basis of the full-length Block 2005
FFQ © (NutritionQuest, Berkeley, CA, USA) and the 2007 national food composition tables [33], to
appropriately adjust for cultural food/beverage items of the Italian pediatric population. Parents
completed the FFQ about their children’s habits during an interview of approximately 50 min,
conducted at hospital by the same experienced dietitian unaware of the obesity status of children.
Each meal was analyzed to find out which food was eaten and how often. Usual portion sizes
were estimated using household measures and the weight (e.g., pasta) or unit (e.g., fruit juice) of
the purchase. A 24-h recall was additionally recorded at the end of the interview to standardize the
usual serving size. Quantification and analysis of the energy intake and nutrient composition were
performed with an ad hoc PC software program developed by a consultant.
2.4. Metabolic Syndrome
Metabolic syndrome was defined in accordance with the International Diabetes Federation (IDF)
criteria for children and adolescents [34,35]. As IDF suggests that below the age of 10 years metabolic
syndrome cannot be diagnosed [34,35], in this study it was evaluated only in children of 10 years
or older.
2.5. Intervention
The intervention was based on promotion of a normocaloric diet, balanced for the macronutrient
distribution, in accordance with the national guidelines for treatment of childhood obesity [36].
Specifically, it was recommended that children follow, for a 1-year period, a normocaloric diet (daily
caloric intake by age and sex [37]) consisting of protein (12%–15%), carbohydrates (55%–60%), fat
(25%–30%; <10% saturated fatty acids, polyunsaturated up to 10%, monounsaturated up to 15%) and
fiber (range: age (year) plus 5 g–age (year) plus 10 g) [36,37]. Additionally, it was recommended
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that children engage in at least 60 min of moderate- to vigorous-intensity physical activity (MVPA)
daily [38], based on walking, and tailored to individual preferences. MVPA was estimated using
3-day physical activity recall (3DPAR). During a first round 1-h educational session, held at hospital
on the day of recruitment, a pediatrician and an experienced dietitian provided illustration and
instructed parents and children about the intervention to be performed and actions to maintain
through a 1-year period. Education was based and focused on regulation of energy expenditure,
body composition, physical activity, consequences of sedentary lifestyle, principles of nutrition, food
sources, glycemic index and glucose metabolism, to continuously enhance and maintain parental and
self-efficacy for dietary change. This education managing also took into account a range of behavior
change techniques from the revised CALO-RE taxonomy (items 1, 2, 5, 6, 8, 16, 21, and 26) [39].
In particular, written guidelines were given to the parents, including general nutritional advice, food
choice lists, selected week menu, and recommended average servings for principal food categories,
according to age and sex. General nutritional advice included increasing fruit and vegetable intake,
increasing legume and fish intake while decreasing meat consumption, using more whole grain food,
avoiding sugary beverages and limiting sweets. Educational and incentive documentation (friendly,
illustrated brochures) about potential benefits of a routinely normocaloric diet and physical activity
for the child and family were also given to parents, together with a diary for recording the physical
activity of their child, in terms of type, frequency, duration and intensity. A second explanatory
session tailored for parents requests was held at the hospital on the day of blood sampling (i.e., within
3 ˘ 1 day of recruitment) to resolve any doubts parents had about intervention, providing them
with an instructive point-by-point reply. Lastly, the study design scheduled a dietitian to contact the
parents by phone on a midweek day at 3-month intervals to fill out a 24-h recall and ask about the
physical activity of the child as recorded in the diary. Parents were also invited to actively contact a
pediatrician by phone (8–20 h) at any time of the intervention, when necessary.
2.6. Outcomes
The primary outcome measures were the change in BMI z-score and HDL cholesterol at the end
of intervention. Secondary measures were the change in the other blood lipid variables and insulin
resistance, and in the prevalence of metabolic syndrome.
2.7. Sample Size
The sample size was calculated iteratively to detect a mean longitudinal variation of 5% or more
of HDL cholesterol, based on the baseline mean and standard deviation estimated in children already
recruited. Assuming a type I error level of 0.05 with a power of 0.80, and allowing for a drop-out of
5% at least 87 children needed to be recruited.
2.8. Statistical Analysis
Descriptive data are reported as mean and standard deviation (SD) or 95% confidence interval
(CI), or number of observations (percentage). Normality of the distribution of continuous variables
was assessed by the Kolmogorov–Smirnov test. Means were adjusted for age, sex and baseline BMI
z-score, as appropriate. Statistical significance of longitudinal variations was tested by the Student’s
t test for paired data or the Wilcoxon test, and also adjusted by ANOVA for repeated measures.
At this analysis non-normally distributed continuous variables entered the model after logarithmic
transformation. All values of p < 0.05 were considered to indicate statistical significance (two-tailed
test). The statistical package for social sciences (SPSS) package version 20.0 (SPSS Inc., Chicago, IL,
USA) for Windows (Microsoft, Redmond, WA, USA) was used, for the statistical analysis.
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3. Results
Eighty-five children (94.4%), 42 boys and 43 girls, completed the intervention. At recruitment,
mean (SD) age and duration of obesity were 9.7 (2.6) years (range 6–15) and 4.0 (2.1) years,
respectively. At the end of intervention there was a reduction of daily energy intake and
macronutrient redistribution towards the recommended range (Table 1). Mean (SD) MVPA was 45.4
(33.2) min/day at baseline and 54.7 (35.0) min/day at the end of intervention (p = 0.089). No change
was observed for systolic (113.33 (11.2) vs. 112.8 (9.5) mmHg; p = 0.524) and diastolic (68.47 (9.25) vs.
67.83 (7.52) mmHg; p = 0.321) blood pressure.
Table 1. Daily dietary intake of energy, macronutrients and fiber, and overall glycemic index and
glycemic load at baseline and at the end of intervention. Values are mean (SD) †.
Variable Baseline (n = 85) End of Intervention(n = 85) p-Value
Recommended
Intake [36,37]
Energy
kcal/day
kcal/kg/day
2460.46 (795.84)
45.43 (18.86)
1855.62 (614.31)
34.39 (16.94)
<0.001 *
0.001 *
1380–3330 kcal/day
depending on age
and sex (6–15 year)
Protein
g/day 96.32 (29.50) 71.12 (23.74) <0.001 * 12%–15% Energy% Energy 15.82 (3.02) 15.54 (3.16) 0.006 *
Carbohydrates
g/day 332.69 (113.51) 268.04 (106.59) <0.001 * 55%–60% Energy% Energy 54.20 (7.19) 58.07 (9.62) 0.001 *
Fats
g/day 84.54 (37.94) 57.27 (21.04) <0.001 * 25%–30% Energy% Energy 31.44 (5.48) 27.97 (4.16) <0.001 *
Saturated
g/day 31.64 (14.40) 19.48 (8.36) <0.001 * <10% Energy% Energy 11.69 (3.07) 9.44 (3.15) <0.001 *
Monounsaturated
g/day 34.53 (15.49) 22.31 (9.28) <0.001 * ď15% Energy% Energy 12.64 (2.87) 10.80 (3.52) 0.022 *
Polyunsaturated
g/day 14.92 (7.20) 9.83 (3.93) <0.001 * ď10% Energy% Energy 5.40 (1.57) 4.72 (1.74) 0.016 *
Fiber g/day 11.30 (5.15) 17.11 (8.02) <0.001 *
age (year) plus
5 g–age (year)
plus 10 g
Overall Glycemic
Index 43.58 (22.42) 41.57 (22.32) 0.146
Glycemic Load 418.73 (565.56) 307.56 (377.64) 0.124
† Mean and p-value adjusted for age and sex; * Statistically significant.
At the end of intervention children showed lower BMI z-score than at recruitment (2.96 (0.96) vs.
3.54 (1.04); p < 0.0001) and lower triceps skinfold thickness (24.05 (5.74) vs. 27.18 (5.42) mm; p < 0.038),
while no difference was found for waist circumference (81.76 (9.88) vs. 83.69 (10.68) cm; p = 0.150).
The within-subject longitudinal variation of obesity status was significant (Figure 1).
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Figure 1. Within-subject longitudinal variation of obesity status through the intervention period 
(figures are number of children). Significance of longitudinal variation was p < 0.0001 (Wilcoxon test). 
HDL cholesterol increased through the intervention period (mean variation, Δ, 0.06; 95% CI, 
(0.01; 0.11) mmol/L) while there was a reduction in triglycerides (−0.35; (−0.45; −0.25) mmol/L) and 
triglycerides/HDL cholesterol ratio (Δ = −0.36; (−0.46; −0.26)) (Table 2). Reduction in triglyceride 
glucose index (−0.29; (−0.37; −0.21)) and prevalence of insulin resistance were observed (Table 3). 
Table 2. Blood lipid profile at baseline and at the end of intervention. Values are mean (SD) †. 
Variable Baseline (n = 85) End of Intervention (n = 85) p-Value 
Total cholesterol (mmol/L) 4.40 (0.62) 4.21 (0.70) 0.072 
LDL cholesterol (mmol/L) 2.58 (0.58) 2.50 (0.65) 0.116 
HDL cholesterol (mmol/L) 1.26 (0.21) 1.32 (0.26) 0.034 * 
Triglycerides (mmol/L) 1.29 (0.66) 0.94 (0.40) 0.024 * 
Apo A1 (g/L) 1.33 (0.23) 1.34 (0.21) 0.772 
Apo B (g/L) 0.76 (0.19) 0.70 (0.17) 0.164 
ApoB/ApoA 0.58 (0.18) 0.54 (0.16) 0.546 
Triglycerides/HDL cholesterol 1.13 (0.77) 0.77 (0.45) 0.018 * 
LDL/HDL cholesterol 2.14 (0.80) 1.99 (0.76) 0.181 
Total cholesterol/HDL cholesterol 3.62 (0.95) 3.34 (0.95) 0.078 
LDL, low-density-lipoprotein; HDL, high-density-lipoprotein; Apo A1, apolipoprotein A1; Apo B, 
apolipoprotein B. SI conversion factors: to convert cholesterol, divide values by 0.0259; to convert 
triglycerides, divide values by 0.0113; to convert Apo A1 and Apo B divide values by 0.01. † Mean and 
p-value adjusted for age, sex, baseline BMI z-score. * Statistically significant. 
Table 3. Glucose metabolism variables at baseline and at the end of intervention. Values are mean 
(SD) † or number of children (percentage). 
Variable Baseline (n = 85) End of Intervention (n = 85) p-Value 
Glucose (mmol/L) 4.78 (0.33) 4.74 (0.29) 0.341 
Insulin (pmol/L) 133.28 (102.22) 98.64 (59.51) 0.399 
HOMA-IR 4.10 (3.30) 3.01 (1.92) 0.281 
HOMA-β% 317.10 (221.23) 237.61 (123.26) 0.368 
QUICK index 0.32 (0.03) 0.33 (0.03) 0.250 
TyG index 8.38 (0.51) 8.09 (0.43) 0.030 * 
Insulin resistance (yes) 44 (51.8) 31 (36.5) 0.008 *,†† 
HOMA-IR, homeostasis model assessment of insulin resistance; QUICK, quantitative insulin sensitivity check; 
TyG, triglyceride glucose. SI conversion factors: to convert glucose, divide values by 0.0555; to convert insulin, 
divide values by 6.945. Insulin resistance (yes): HOMA-IR >3.16. † Mean and p-value adjusted for age, sex, baseline 
BMI z-score. †† Wilcoxon test. * Statistically significant. 
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(figures are number of children). Significance of longitudinal variation was p < 0.0001 (Wilcoxon test).
HDL cholesterol increased through the intervention period (mean variation, ∆, 0.06; 95% CI,
(0.01; 0.11) mmol/L) while there was a reduction in triglycerides (´0.35; (´0.45; ´0.25) mmol/L) and
triglycerides/HDL cholesterol ratio (∆ = ´0.36; (´0.46; ´0.26)) (Table 2). Reduction in triglyceride
glucose index (´0.29; (´0.37; ´0.21)) and prevalence of insulin resistance were observed (Table 3).
Table 2. Blood lipid profile at baseline and at the end of intervention. Values are mean (SD) †.
Variable Baseline (n = 85) End of Intervention (n = 85) p-Value
Total cholesterol (mmol/L) 4.40 (0.62) 4.21 (0.70) 0.072
LDL cholesterol mol/L) 2.58 (0.58) 2.50 (0.65) 0.116
HDL cholesterol (mmol/L) 1.26 (0.21) 1.32 (0.26) 0.034 *
Triglycerides (m ol/L) 1.29 (0.66) 0.94 (0.40) 0.024 *
Apo A1 (g/L) 1.33 (0.23) 1.34 (0.21) 0.772
Apo B (g/L) 0.76 (0.19) 0.70 (0.17) 0.164
ApoB/ApoA 0.58 (0.18) 0.54 (0.16) 0.546
Triglycerides/HDL cholesterol 1.13 (0.77) 0.77 (0.45) 0.018 *
LDL/HDL cholesterol 2.14 (0.80) 1.99 (0.76) 0.181
Total cholesterol/HDL
cholesterol 3.62 (0.95) 3.34 (0.95) 0.078
LDL, low-density-lipoprotein; HDL, high-density-lipoprotein; Apo A1, apolipoprotein A1; Apo B,
apolipoprotein B. SI conversion factors: to convert cholesterol, divide values by 0.0259; to convert triglycerides,
divide values by 0.0113; to c nvert Apo A1 and Apo B divide values by 0.01. † Mean and p-value adjusted for
age, sex, baseline BMI z-score. * Statistically significant.
Table 3. Glucose metabolism variables at baseline and at the end of intervention. Values are mean
(SD) † or number of children (percentage).
Variable Baseline (n = 85) End of Intervention (n = 85) p-Value
Glucose (mmol/L) 4.78 (0.33) 4.74 (0.29) 0.341
Insulin (pmol/L) 133.28 (102.22) 98.64 (59.51) 0.399
HOMA-IR 4.10 (3.30) 3.01 (1.92) 0.281
HOMA-β% 317.10 (221.23) 237.61 (123.26) 0.368
QUICK index 0.32 (0.03) 0.33 (0.03) 0.250
TyG index 8.38 (0.51) 8.09 (0.43) 0.030 *
Insulin resistance (yes) 44 (51.8) 31 (36.5) 0.008 *,††
HOMA-IR, homeostasis model assessment of insulin resistance; QUICK, quantitative insulin sensitivity check;
TyG, triglyceride glucose. SI conversion factors: to convert glucose, divide values by 0.0555; to convert insulin,
divide values by 6.945. Insulin resistance (yes): HOMA-IR >3.16. † Mean and p-value adjusted for age, sex,
baseline BMI z-score. †† Wilcoxon test. * Statistically significant.
At the end of intervention, prevalence of metabolic syndrome was reduced by 71.4% (Table 4).
No component worsened for any child. The only child who had waist circumference decreased below
the 90th percentile was not syndromic at baseline. Fourteen children recovered one of the other
metabolic components and two children recovered 2 components.
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At 3, 6, 9 and 12 months of intervention, compliance with diet and MVPA, evaluated by the 24-h
recall (plus FFQ at 12 months) and diary of physical activity, was 84%, 86%, 88% and 92% (diet) and
83%, 86%, 85% and 87% (MVPA), respectively.
Table 4. Distribution of children according to International Diabetes Federation criteria for metabolic
syndrome † [34,35] at baseline and at the end of intervention. Values are number of children
(percentage).
Baseline (n = 41) End of Intervention (n = 41) p-Value ††
Metabolic syndrome 7 (17.1) 2 (4.9) 0.025 *
Component
Waist circumferenceě90th percentile 40 (97.6) 39 (95.1) 0.317
Triglyceridesě1.7 mmol/L 10 (24.4) 3 (7.3) 0.008 *
HDL cholesterol <1.03 mmol/L 12 (29.3) 7 (17.1) 0.025 *
Blood pressure: Systolicě130/Diastolic
ě85 mmHg 9 (22) 3 (7.3) 0.034 *
Glucoseě5.6 mmol/L 0 (0) 0 (0) 1.000
HDL, high-density-lipoprotein. SI conversion factors: to convert cholesterol, divide values by 0.0259; to
convert triglycerides, divide values by 0.0113. † Evaluated in children aged ě10 years (20 boys, 21 girls).
Diagnosis of metabolic syndrome requires waist circumference ě90th percentile and two or more of the other
components. †† Wilcoxon test. * Statistically significant.
4. Discussion
This longitudinal study evaluated whether a 1-year nutritional-behavioral intervention, based
on normocaloric balanced diet and physical activity, may impact the BMI status and metabolic profile
of obese children aged ě6 years. The participation rate was high, ranging from 100% at baseline to
94.4% at the end of intervention. Strict international definitions and accurate anthropometric and
biochemistry measurement procedures were used. Compliance with treatment, as based on national
recommended dietary energy and macronutrient intakes [36,37], was acceptable, with more than 90%
of children who recovered at the end of intervention towards the recommended range. However,
owing to the study design, which did not include a control group of obese children on a free diet, and
based on the dietary assessment on the Food Frequency Questionnaire, caution should be exercised
in drawing definitive conclusions. Indeed, it should be pointed out that while the absence of a
control group on a free diet is a limitation, the recruitment of such a group was discouraged by the
Hospital Ethics Committee due to the opinion that all obese children and their families should have
the same opportunity to be instructed about dietary recommendations, while also taking into account
the current international guidelines [9]. The use of the FFQ and 24-h recall, instead of a three- or
seven-day food diary, was chosen as it provides for immediate collection of data and because the
dietary assessment was primarily planned to estimate compliance with intervention and not its effect
size. Another limitation is that the study did not fully meet the revised CALO-RE taxonomy [39].
Indeed, while the revised CALO-RE taxonomy was not available before starting this study, only a
subset of items was extracted by a consultant psychologist from the original 26-item taxonomy [40]
due to financial constraints. Regardless, it should be noted that most of the selected items have been
recently recognized as providing effective behavior change techniques for childhood obesity [41].
At the end of intervention, children showed a decrease in mean BMI z-score of 16%, and
25% of them recovered from obesity to overweight. Other studies [15–19,42,43] conducted on
overweight/obese children found, at the end of nutritional/lifestyle interventions, a decrease in
mean BMI z-score, ranging from about 5% [18,19] to 20% [15]. In this study no overall significant
change was detected for waist circumference while a decrease in triceps skinfold thickness was
observed. It should be pointed out that skinfold thickness is de facto a measure of subcutaneous fat
unable to quantify visceral adiposity, while waist circumference is a useful indicator for identifying
children at increased risk of cardiovascular disease and metabolic syndrome [44]. The authors
observed a waist circumference decrease in obese/overweight children after lifestyle interventions
based on hypocaloric diet [43] or not [15,16,19] while no change of waist circumference was
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detected in obese/overweight children aged 7–9 years after a 1-year lifestyle intervention based on
a recommended dietary allowance of about 1800 kcal or nutrition education program [17]. A study
conducted on 484 children who underwent a 1-year intervention based on physical activity, nutrition
education, and behavior therapy found decreased blood pressure [16]. In this study no significant
change was observed in mean blood pressure, as was also found in a trial that evaluated the effects
of a 20-week exercise and diet guidance intervention on 19 overweight school-aged children [15].
HDL cholesterol and triglycerides have a key role in cardiovascular disease. HDL cholesterol
protects against vascular disease by removing the “bad” cholesterol from the walls of arteries while
high triglycerides increase the risk of atherosclerotic cardiovascular disease [45]. In our study,
increased HDL cholesterol and decreased triglycerides levels were found. While these findings agree
with other studies [16,17,43], it should be noted that a recent systematic review and meta-analysis
examining the impact of lifestyle interventions, including dietary caloric restrictions and/or nutrition
education, on cardio-metabolic risk factors in overweight/obese children reported that fewer than
half of evaluated studies demonstrated significant improvements in HDL cholesterol or triglycerides
levels [12]. The same authors [13] suggested that diet plus exercise interventions may produce greater
improvement in HDL cholesterol than diet-only interventions. Concerning the other lipid variables,
no improvement in total cholesterol, LDL cholesterol, Apolipoprotein A1 and Apolipoprotein B
was observed while other authors reported a significant change of at least one of these lipid
variables [16–18,43].
Lifestyle interventions based on a hypocaloric diet [43] or not [16,18] reported decreased insulin
and/or HOMA-IR after one year of intervention. In this study, the change in insulin, HOMA-IR,
HOMA-β% and QUICK index was not statistically significant. However it should be noted that
the prevalence of insulin resistance decreased by 30%, from a baseline value of 51.8%, which is
comparable with estimates reported in the literature, ranging from 32% [46] to 52% [47]. Triglyceride
glucose index is an emergent useful indicator, affording an easily and widely available simple
laboratory method as a surrogate to estimate the insulin sensitivity [30,31]. Only one study examined
its usefulness in pediatric age, suggesting that it could be used in the metabolic evaluation of
obese adolescents [31]. To our knowledge this study is the first intervention study that evaluated
triglyceride glucose index in a pediatric population, and found that it decreased at the end of the
intervention. This result also suggests that assessment of triglyceride glucose index might be included
in future research investigating on glucose-metabolism alterations in obese children.
Metabolic syndrome was firstly defined in adult population as “a link between insulin
resistance, hypertension, dyslipidemia, impaired glucose tolerance and other metabolic abnormalities
associated with an increased risk of athero-sclerotic cardiovascular diseases” [48] and it has also been
successively defined in the pediatric population. Recently, the International Diabetes Federation has
suggested a unified definition that can be profitably used in children [35]. In this study, the prevalence
of metabolic syndrome, defined according to IDF criteria [34,35], was 17% and 5% at, respectively, the
baseline and the end of intervention. Reinehr et al. [49], when using the IDF definition, found in obese
children a comparable decline of prevalence, going from 19% to 9% after 1-year lifestyle intervention.
Other authors found a variation of prevalence from 17% to 10%, after 1-year lifestyle intervention
characterized by a diet with a caloric intake 250–500 kcal less per day than the daily requirement, but
variation was not statistically significant [43].
Concerning specific components of metabolic syndrome, the percentage of children with blood
level of triglycerides ě1.7 mmol/L, lower levels of HDL cholesterol and high systolic or diastolic
blood pressure significantly declined by 70%, 42% and 67%, respectively. In the study conducted
by Reinehr et al. [49] variation of IDF components was significant for blood pressure only, with a
reduction of about 50%. Direct comparison with findings reported in other studies is not here possible
due to the different adopted definition of the metabolic syndrome (e.g., [17]).
On the whole, within the limitations of this study, one may conclude that in obese children,
interventions based on normocaloric diet and physical activity could result in a decrease of BMI
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z-score and also benefit blood lipid profile and insulin sensitivity. Additionally, it might play a
positive role in terms of metabolic syndrome. Large longitudinal trials with adequate power, and
hopefully meeting the revised CALO-RE taxonomy, are desirable to better evaluate the clinical
relevance and long-term effectiveness of nutritional-behavioral interventions based on normocaloric
diet and physical activity.
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